Richard Charles Dowell | |
---|---|
Born | Australia | August 31, 1957
Nationality | Australian |
Occupation(s) | Audiologist, academic and researcher |
Title | Graeme Clark Chair in Audiology and Speech Science |
Awards | Fellow of Audiology Australia |
Academic background | |
Education | Bachelor of Science, physics and pure mathematics Master of Science, Audiology Doctor of Philosophy |
Alma mater | University of Melbourne |
Thesis | Speech perception in noise for multichannel cochlear implant users (1991) |
Academic work | |
Institutions | University of Melbourne |
Richard Charles Dowell is an Australian audiologist,academic and researcher. He holds the Graeme Clark Chair in Audiology and Speech Science at University of Melbourne. He is a former director of Audiological Services at Royal Victorian Eye and Ear Hospital. [1]
Dowell's research is centered on hearing loss;he has been involved in clinical work and research in cochlear implants,along with developing signal processing improvements for cochlear implants. [2]
Dowell is a Fellow of Audiology Australia. He is a former Chair of the Victorian Infant Hearing Screening Program Audiological committee and a former Chair of the Taralye Early Intervention center for hearing impaired children in Melbourne. [3]
After completing his initial studies at Carey Baptist Grammar School,Dowell studied at the University of Melbourne where he completed his Bachelor of Science in 1977,Graduate Diploma in Audiology in 1979,Masters in Audiology in 1989 and his Doctoral studies in 1991. [1]
Dowell began his career as a Research Audiologist at the University of Melbourne Department of Otolaryngology in 1980 before being promoted to Lecturer of Audiology in 1989 and to Senior Lecturer in 1991. In 1995,Dowell was promoted to Associate Professor and then Professor of Audiology from 2001 till 2013. He was appointed the Graeme Clark Chair in Audiology and Speech Science in 2013. [1]
At the university,Dowell was appointed as Head of the Department of Otolaryngology from 2005 till 2011,and for the Department of Audiology and Speech Pathology from 2012 till 2018. [1]
Along with his academic career at University of Melbourne,Dowell has also held clinical and hospital appointments. He devised and implemented the initial clinical trial of the multichannel cochlear implant for adults,and established and directed the Cochlear Implant Clinic at the Royal Victorian Eye and Ear Hospital with Professor Graeme Clark. [4]
Dowell has conducted significant research on hearing impairment,particularly in relation to cochlear implants. He contributed to the development of many of the clinical procedures in the cochlear implant field and to signal processing improvements for these prostheses. Dowell was a key contributor to the first successful FDA approval of multi-channel cochlear implants in adults (1985) and children (1990). [5]
Dowell studied the psychophysical properties of electrical stimuli presented to cochlear implant patients with colleagues Graeme Clark,Yit Chow Tong,and Peter Blamey. These studies resulted in publications that established some of the fundamental basic science for electrical hearing. [6]
Dowell then devised the initial clinical trial of the first commercial multichannel cochlear implant resulting in FDA approval for adults with profound hearing loss in 1985. [7]
With colleagues,Peter Seligman and Blamey,Dowell helped to develop the initial sound coding algorithms for the multichannel cochlear implant. [8]
Dowell,working with Blamey and others,established factors predictive of outcomes for adults who received cochlear implants. [9] This study was followed up in 2013 by Blamey and Dowell,with other colleagues,who collected data for 2251 adults who used cochlear implants to study the factors affecting auditory performance. The study found that the history and duration of hearing loss,age and other factors were associated with cochlear implant outcomes,but that no single factor had good predictive power. [10]
In 2006,Dowell with PhD student Mansze Mok,published a study to address the use of cochlear implants in conjunction with conventional hearing aids in the opposite ear. The study showed that acoustic hearing can provide complementary information to that provided by a cochlear implant and thus improve speech understanding. [11]
Dowell worked on identifying the factors affecting the speech perception scores among children using cochlear implants. A large sample of children using the Nucleus 22-electrode cochlear implant and having an average age of 5 years at the time of implantation were evaluated. Multivariate analysis identified six factors,including age at implantation,educational approach,progression of hearing loss and developmental delay that were predictive for speech perception scores. [12]
In the mid-2000s,Dowell,with colleague and wife Shani Dettman amongst others,studied the risks and benefits regarding the communication development of children who received cochlear implant surgery before 12 months of age. The study showed that spoken language acquisition for deaf children depended significantly on access to auditory input in their first year. [13]
Dowell has been involved in research into auditory neuropathy with colleague Gary Rance,that established the diagnostic and management procedures for this distinct type of hearing loss identified in the late 1990s. [14]
Dowell has also been involved in research into the evaluation and management of vestibular disorders,the use of electrophysiological techniques in diagnostic audiology,and evaluation of hearing deficits of non-peripheral origin. [2]
A cochlear implant (CI) is a surgically implanted neuroprosthesis that provides a person who has moderate-to-profound sensorineural hearing loss with sound perception. With the help of therapy, cochlear implants may allow for improved speech understanding in both quiet and noisy environments. A CI bypasses acoustic hearing by direct electrical stimulation of the auditory nerve. Through everyday listening and auditory training, cochlear implants allow both children and adults to learn to interpret those signals as speech and sound.
Audiology is a branch of science that studies hearing, balance, and related disorders. Audiologists treat those with hearing loss and proactively prevent related damage. By employing various testing strategies, audiologists aim to determine whether someone has normal sensitivity to sounds. If hearing loss is identified, audiologists determine which portions of hearing are affected, to what degree, and where the lesion causing the hearing loss is found. If an audiologist determines that a hearing loss or vestibular abnormality is present, they will provide recommendations for interventions or rehabilitation.
Auditory neuropathy (AN) is a hearing disorder in which the outer hair cells of the cochlea are present and functional, but sound information is not transmitted sufficiently by the auditory nerve to the brain. The cause may be several dysfunctions of the inner hair cells of the cochlea or spiral ganglion neuron levels. Hearing loss with AN can range from normal hearing sensitivity to profound hearing loss.
Presbycusis, or age-related hearing loss, is the cumulative effect of aging on hearing. It is a progressive and irreversible bilateral symmetrical age-related sensorineural hearing loss resulting from degeneration of the cochlea or associated structures of the inner ear or auditory nerves. The hearing loss is most marked at higher frequencies. Hearing loss that accumulates with age but is caused by factors other than normal aging is not presbycusis, although differentiating the individual effects of distinct causes of hearing loss can be difficult.
Graeme Milbourne Clark is an Australian Professor of Otolaryngology at the University of Melbourne. Worked in ENT surgery, electronics and speech science contributed towards the development of the multiple-channel cochlear implant. His invention was later marketed by Cochlear Limited.
The auditory brainstem response (ABR), also called brainstem evoked response audiometry (BERA) or brainstem auditory evoked potentials (BAEPs) or brainstem auditory evoked responses (BAERs) is an auditory evoked potential extracted from ongoing electrical activity in the brain and recorded via electrodes placed on the scalp. The measured recording is a series of six to seven vertex positive waves of which I through V are evaluated. These waves, labeled with Roman numerals in Jewett and Williston convention, occur in the first 10 milliseconds after onset of an auditory stimulus. The ABR is considered an exogenous response because it is dependent upon external factors.
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Electric acoustic stimulation (EAS) is the use of a hearing aid and a cochlear implant technology together in the same ear. EAS is intended for people with high-frequency hearing loss, who can hear low-pitched sounds but not high-pitched ones. The hearing aid acoustically amplifies low-frequency sounds, while the cochlear implant electrically stimulates the middle- and high-frequency sounds. The inner ear then processes the acoustic and electric stimuli simultaneously, to give the patient the perception of sound.
Cortical deafness is a rare form of sensorineural hearing loss caused by damage to the primary auditory cortex. Cortical deafness is an auditory disorder where the patient is unable to hear sounds but has no apparent damage to the structures of the ear. It has been argued to be as the combination of auditory verbal agnosia and auditory agnosia. Patients with cortical deafness cannot hear any sounds, that is, they are not aware of sounds including non-speech, voices, and speech sounds. Although patients appear and feel completely deaf, they can still exhibit some reflex responses such as turning their head towards a loud sound.
An auditory brainstem implant (ABI) is a surgically implanted electronic device that provides a sense of sound to a person who is profoundly deaf, due to retrocochlear hearing impairment. In Europe, ABIs have been used in children and adults, and in patients with neurofibromatosis type II.
Prelingual deafness refers to deafness that occurs before learning speech or language. Speech and language typically begin to develop very early with infants saying their first words by age one. Therefore, prelingual deafness is considered to occur before the age of one, where a baby is either born deaf or loses hearing before the age of one. This hearing loss may occur for a variety of reasons and impacts cognitive, social, and language development.
Deafness has varying definitions in cultural and medical contexts. In medical contexts, the meaning of deafness is hearing loss that precludes a person from understanding spoken language, an audiological condition. In this context it is written with a lower case d. It later came to be used in a cultural context to refer to those who primarily communicate through sign language regardless of hearing ability, often capitalized as Deaf and referred to as "big D Deaf" in speech and sign. The two definitions overlap but are not identical, as hearing loss includes cases that are not severe enough to impact spoken language comprehension, while cultural Deafness includes hearing people who use sign language, such as children of deaf adults.
The Bionics Institute is an Australian medical research institute focusing on medical device development. It is located in Melbourne, Australia.
Claude-Henri Chouard is a French surgeon. An otologist, he has been a full member of the Académie Nationale de Médecine since 1999. He was director of the AP-HP Laboratory of Auditory Prosthesis and director of the ENT Research Laboratory at Paris-Saint-Antoine University Hospital from 1967 to 2001. He was also head of the institution's ENT Department from 1978 to 1998. In 1982, he was elected a member of the International Collegium ORL-AS. He achieved worldwide recognition in the late 1970s thanks to the work completed by his Paris laboratory's multidisciplinary team on the multichannel cochlear implant. This implanted electronic hearing device was developed at Saint-Antoine and alleviates bilateral total deafness. When implanted early in young children, it can also help overcome the spoken language problems associated with deafness.
Monita Chatterjee is an auditory scientist and the Director of the Auditory Prostheses & Perception Laboratory at Boys Town National Research Hospital. She investigates the basic mechanisms underlying auditory processing by cochlear implant listeners.
Temporal envelope (ENV) and temporal fine structure (TFS) are changes in the amplitude and frequency of sound perceived by humans over time. These temporal changes are responsible for several aspects of auditory perception, including loudness, pitch and timbre perception and spatial hearing.
Robert V. Shannon is Research Professor of Otolaryngology-Head & Neck Surgery and Affiliated Research Professor of Biomedical Engineering at University of Southern California, CA, USA. Shannon investigates the basic mechanisms underlying auditory neural processing by users of cochlear implants, auditory brainstem implants, and midbrain implants.
Quentin Summerfield is a British psychologist, specialising in hearing. He joined the Medical Research Council Institute of Hearing Research in 1977 and served as its deputy director from 1993 to 2004, before moving on to a chair in psychology at The University of York. He served as head of the Psychology department from 2011 to 2017 and retired in 2018, becoming an emeritus professor. From 2013 to 2018, he was a member of the University of York's Finance & Policy Committee. From 2015 to 2018, he was a member of York University's governing body, the Council.
Elaine Saunders is an associate professor at the Swinburne University of Technology and executive director of Blamey Saunders, as well as an inventor, entrepreneur. She was elected a Fellow of the Australian Academy of Science Technology and Engineering in 2019. She is one of only nine women out of 160 to win the Clunies Ross award for entrepreneurship, and has won many other awards, as well as given numerous keynote addresses on the value of entrepreneurship and innovation in STEMM.
Judy R. Dubno is an American scientist and researcher in the field of audiology. She is a distinguished university professor and director of research in the department of otolaryngology at the Medical University of South Carolina in Charleston. She is recognized for her scientific contributions to the understanding of presbycusis, a condition of hearing loss that occurs gradually for many aging adults. She has been involved in the development and implementation of several new methods for assessing hearing loss, including the Hearing in Noise Test (HINT) and Speech Intelligibility Index (SII). She has won numerous awards for her work, including the Jerger Career Award for Research in Audiology in 2011. She served as President of the Acoustical Society of America from 2014 to 2015.